Literature DB >> 92529

Stimulation of active E-rosette forming lymphocytes by myelin basic protein and specific antigens from multiple sclerosis brains.

H Offner, S C Rastogi, G Konat, J Clausen.   

Abstract

Peripheral blood lymphocytes from 30 patients with multiple sclerosis (MS) responded to low doses (i.e. 0.1--5 pg total protein) of crude MS myelin basic protein (BP) as assayed by the active E-rosette test (AER). Of the MS patients studied 20 (65%) responded to control BP. The optimum response of MS lymphocytes to MS BP was obtained at a lower concentration than their response to control BP. Thirty percent of other neurological patients (OND) were stimulated by both MS and control BP. Lymphocytes of all MS patients but none of the OND responded to partially purified protein fraction of MS brain ("peak 2"). Crossed immunoelectrophoresis revealed the presence of one common specific antigen in crude MS BP and MS "peak 2" antigens. The nature of these antigens is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92529     DOI: 10.1016/0022-510x(79)90168-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  MS-related material in blood of multiple sclerosis patients: results with the leucocyte adherence inhibition assay.

Authors:  R Lehmitz; U Meyer; H J Meyer-Rienecker
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

2.  Loss of lysosomal neutral proteinase from leucocytes induced by the action of multiple sclerosis-specific brain antigens.

Authors:  S C Rastogi; J Clausen
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

3.  On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis.

Authors:  A Turner; M L Cuzner; A N Davison; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

4.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.